Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Metabolism”

2,020 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,020 results

Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Not applicableUnknownNCT03617744
What this trial is testing

Sleeve Gastrectomy for Morbid-Obesity Sequelae After Transplantation

Who this might be right for
Liver TransplantationObesity
University Health Network, Toronto 50
Not applicableNot Yet RecruitingNCT07820800
What this trial is testing

NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)

Who this might be right for
Type 2 DiabetesCoronary Heart DiseaseMyocardial Infarction+4 more
University of Eastern Finland 1,400
Not applicableStudy completedNCT01834300
What this trial is testing

The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Liverpool 60
Not applicableNot Yet RecruitingNCT06483711
What this trial is testing

Reducing Barriers to Lifestyle Modification for Newly Diagnosed MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Stanford University 50
Not applicableStudy completedNCT02383485
What this trial is testing

Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children

Who this might be right for
Overweight and ObesityNon-alcoholic Fatty Liver Disease
Augusta University 175
Not applicableStudy completedNCT05546450
What this trial is testing

Effect of Lyophilized Cornus Mas L. on Anthropometric and Biochemical Parameters in Metabolic Associated Fatty Liver Disease Patients

Who this might be right for
Fatty Liver DiseaseObesityLiver Fat
Istanbul Gelisim University 108
Not applicableActive Not RecruitingNCT04829110
What this trial is testing

Alcohol Induced de Novo Lipogenesis in Women

Who this might be right for
Liver Metabolism
University of Texas Southwestern Medical Center 27
Not applicableUnknownNCT05560997
What this trial is testing

Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseMachine Learning
Yan Bi 1,000
Not applicableStudy completedNCT02597790
What this trial is testing

A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects

Who this might be right for
HIVHepatitis C
University of California, Los Angeles 87
Post-approval studies (Phase 4)UnknownNCT03987893
What this trial is testing

PEG3350 in ACLF With Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyAcute-On-Chronic Liver Failure
Post Graduate Institute of Medical Education and Research, Chandigarh 60
Not applicableEnded earlyNCT02545114
What this trial is testing

Tolvaptan for Patients With Acute Neurological Injuries

Who this might be right for
HyponatremiaSIADH
Polderman, Kees, H., MD, PhD 25
Not applicableLooking for participantsNCT07246421
What this trial is testing

Glucagon Resistance in Patients With MASLD and T2DM

Who this might be right for
Metabolic Associated Fatty Liver DiseaseType 2 Diabetes (T2DM)
University of Aarhus 24
Not applicableLooking for participantsNCT04096014
What this trial is testing

Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
The Cleveland Clinic 40
Not applicableEnded earlyNCT02345421
What this trial is testing

Identify and Characterize LAL-D Patients in High-risk Populations

Who this might be right for
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals, Inc. 640
Large-scale testing (Phase 3)Looking for participantsNCT06528314
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisMASH - Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, Inc 2,150
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Large-scale testing (Phase 3)UnknownNCT01087242
What this trial is testing

Clinical Trail of Tang-min-Ling Pills in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 480
Testing effectiveness (Phase 2)Study completedNCT02595983
What this trial is testing

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

Who this might be right for
Transthyretin (TTR)-Mediated AmyloidosisFamilial Amyloidotic Polyneuropathy (FAP)ATTR Amyloidosis+1 more
Alnylam Pharmaceuticals 12
Next Page